The US Food and Drug Administration has published its latest quarterly batch of product-specific guidances for generic development, comprising 68 documents that include 14 brand new and 54 newly-revised PSGs.
Latest FDA Product-Specific Guidances Cover Inhalers, Ear Drops And Paxlovid
Agency’s 68 PSGs Include 14 New And 54 Newly-Revised Generic Guidance Documents
The latest batch of product-specific guidances for generic development has been published by the US Food and Drug Administration, covering products that include COVID-19 treatment Paxlovid, ear drops and various metered-dose inhalers.